BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001


SEARCH JOBS




Industry
Services






 Company News
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/25/2015 6:43:16 AM
Novartis AG (NVS) Presents Cosentyx Two-Year Efficacy And Safety Data Showing Sustainable Effect In Psoriasis Patients 3/23/2015 7:35:48 AM
Eli Lilly (LLY),Novartis AG (NVS)-Backed Startup, Aeglea, Nabs $44 Million 3/23/2015 6:32:01 AM
New Novartis AG (NVS) Data Show More Cosentyx-Treated Psoriasis Patients Achieved Clear Or Almost Clear Skin (PASI 90) Compared To Stelara 3/20/2015 11:35:05 AM
Novartis AG (NVS) Eliminates 89 Jobs in New York 3/20/2015 7:04:44 AM
Amgen (AMGN) Devastated as Novartis AG (NVS) Wins Approval to Sell First-of-a-Kind Copycat Drug 3/20/2015 6:19:29 AM
Ex-Workers Accuse Novartis AG (NVS)'s Alcon (ACL) of Being Sexist, Maintaining a Boy's Club Atmosphere 3/18/2015 5:57:15 AM
Novartis AG (NVS) Employees Brace for More Cuts and Consolidation 3/11/2015 6:31:27 AM
Novartis AG (NVS) Release: FDA Approves First Biosimilar Zarxi (Filgrastim-Sndz) From Sandoz, Inc. 3/6/2015 7:46:53 AM
Novartis AG (NVS)'s Sandoz Bags Approval for First Biosimilar to be Sold in the U.S. 3/6/2015 7:44:03 AM
12345678910...